MARGARET MANTZ: Open Payments
NPI 1679915672 · NEWARK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,307 in 41 payments from 10 companies in 2025. Trend: 2023 $924 · 2024 $2,838 · 2025 $2,307
Food & beverage: $2,020Travel & lodging: $286
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 9 | $621 |
| Nalu Medical, Inc. | 6 | $572 |
| Globus Medical, Inc. | 12 | $541 |
| Baxter Healthcare | 2 | $243 |
| Abbott Laboratories | 7 | $214 |
| Tandem Diabetes Care, Inc. | 1 | $29 |
| Cala Health, Inc. | 1 | $28 |
| Neuros Medical, Inc. | 1 | $23 |
| Saluda Medical Americas, Inc. | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $18 |
Products named: General - DBS, Nalu Neurostimulation System, Senza, ACTIFUSE, INFINITY, t:slim X2 Insulin Pump with Control-IQ, Cala kIQ, General - Pain Management.
Industry payments across NJ — which companies pay providers there.
